Diabetes Care Devices - Mauritius

  • Mauritius
  • Revenue in the Diabetes Care Devices market market in Mauritius is anticipated to reach US$4.08m in 2024.
  • The revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 14.50%, leading to a market volume of US$8.03m by 2029.
  • In a global context, the majority of revenue will be produced the United States, which is expected to generate US$11,710.00m in 2024.
  • In Mauritius, the increasing prevalence of diabetes is driving innovation and investment in advanced diabetes care devices to enhance patient management and outcomes.

Key regions: Netherlands, Japan, France, Italy, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diabetes Care Devices Market in Mauritius is witnessing substantial growth, fueled by factors such as increasing diabetes prevalence, advancements in technology, and heightened awareness of diabetes management among the population, enhancing patient outcomes and convenience.

Customer preferences:
Consumers in Mauritius are increasingly inclined towards personalized diabetes care solutions, reflecting a growing demand for smart glucose monitors and mobile health applications that offer real-time data and insights. This shift is influenced by a rising middle class and a younger demographic that values convenience and technology in managing health. Additionally, cultural factors emphasizing family support in health decisions have led to more collaborative approaches in diabetes management, with families actively participating in lifestyle changes and device usage to improve overall well-being.

Trends in the market:
In Mauritius, the Diabetes Care Devices market is experiencing a notable shift towards integrated health management solutions, with an increasing adoption of smart insulin delivery systems and continuous glucose monitoring devices. This trend is driven by a tech-savvy younger population seeking efficient ways to manage diabetes, alongside a supportive healthcare framework that promotes innovation. Moreover, mobile health applications are becoming pivotal in facilitating real-time data sharing among healthcare providers and families, enhancing collaborative care. The implications for industry stakeholders include the need for partnerships with tech firms and a focus on user-friendly device design to meet evolving consumer expectations.

Local special circumstances:
In Mauritius, the Diabetes Care Devices market is shaped by its unique geographical and cultural landscape, characterized by a diverse population and a high prevalence of diabetes. The island's limited healthcare infrastructure propels demand for portable and user-friendly diabetes management devices, allowing patients to monitor their health on the go. Additionally, cultural attitudes emphasize community support in health management, fostering collaborative care models. Regulatory frameworks are evolving to facilitate the introduction of innovative technologies, further stimulating the growth of personalized diabetes solutions and telehealth services.

Underlying macroeconomic factors:
The Diabetes Care Devices market in Mauritius is significantly influenced by macroeconomic factors such as national economic stability, healthcare spending, and global economic trends. With Mauritius experiencing steady economic growth, increased disposable income enables greater investment in diabetes management technologies. Fiscal policies promoting healthcare innovation and subsidies for medical devices further enhance market accessibility. Additionally, rising global health awareness and the increasing prevalence of diabetes create a robust demand for advanced diabetes care solutions. The integration of telehealth services, driven by both local and international investment, is also shaping the delivery of diabetes care, ensuring patients have better access to essential monitoring tools.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)